CTKB icon

Cytek Biosciences
CTKB

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$6.25
16% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
TD Cowen
TD Cowen
Brendan Smith
0% 1-yr CTKB win rate
8 Jan ‘26 9 days ago
Piper Sandler
Piper Sandler
David Westenberg
100% 1-yr CTKB win rate
11 Nov ‘25 2 months ago